Search research articles
Contact Us
Filters
Showing results (11-20 of 526) with videos related to
Page
of 53
Sort By:
Die Rehabilitation
|
May 17, 2019
[Prescription and Utilization of Sports Therapy Programs following Cardiac Rehabilitation 2006-2013]
Lars Gabrys, Christian Schmidt
Hematology/Oncology Clinics of North America
|
October 29, 2008
Therapy of mantle cell lymphoma: current standards and future strategies
Christian Schmidt, Martin Dreyling
The Lancet. Haematology
|
January 5, 2025
The challenges of detecting early efficacy signals in lymphoma trials
Eva Hoster, Christian Schmidt
Biomedicines
|
May 25, 2017
Nanomaterials-Tools, Technology and Methodology of Nanotechnology Based Biomedical Systems for Diagnostics and Therapy
Christian Schmidt, Joachim Storsberg
Molecular Cancer
|
July 5, 2007
An open democracy
Shawn Mathur, Christian Schmidt
Leukemia & Lymphoma
|
February 13, 2010
Rituximab in relapsed aggressive lymphoma: play it again, Sam?
Martin Dreyling, Christian Schmidt
Journal of Health Monitoring
|
May 19, 2022
Germany's Data Transparency Regulations - potential, developments and RKI federal health reporting activities
Alexander Rommel, Christian Schmidt
Molecular Cancer
|
October 24, 2003
TGFbeta1 activates c-Jun and Erk1 via alphaVbeta6 integrin
Karsta Luettich, Christian Schmidt
European Neurology
|
October 27, 2017
A Callosal Lesion
Christian Schmidt, Mark Obermann
Diseases (Basel, Switzerland)
|
January 3, 2018
Risk Evaluation Requires an Independent Mind
Christian Schmidt, Joachim Storsberg
Page
of 53
Search research articles
Search
Showing results (11-20 of 526) with videos related to
Sort By:
Page
of 53
Die Rehabilitation
|
May 17, 2019
[Prescription and Utilization of Sports Therapy Programs following Cardiac Rehabilitation 2006-2013]
Lars Gabrys, Christian Schmidt
Hematology/Oncology Clinics of North America
|
October 29, 2008
Therapy of mantle cell lymphoma: current standards and future strategies
Christian Schmidt, Martin Dreyling
The Lancet. Haematology
|
January 5, 2025
The challenges of detecting early efficacy signals in lymphoma trials
Eva Hoster, Christian Schmidt
Biomedicines
|
May 25, 2017
Nanomaterials-Tools, Technology and Methodology of Nanotechnology Based Biomedical Systems for Diagnostics and Therapy
Christian Schmidt, Joachim Storsberg
Molecular Cancer
|
July 5, 2007
An open democracy
Shawn Mathur, Christian Schmidt
Leukemia & Lymphoma
|
February 13, 2010
Rituximab in relapsed aggressive lymphoma: play it again, Sam?
Martin Dreyling, Christian Schmidt
Journal of Health Monitoring
|
May 19, 2022
Germany's Data Transparency Regulations - potential, developments and RKI federal health reporting activities
Alexander Rommel, Christian Schmidt
Molecular Cancer
|
October 24, 2003
TGFbeta1 activates c-Jun and Erk1 via alphaVbeta6 integrin
Karsta Luettich, Christian Schmidt
European Neurology
|
October 27, 2017
A Callosal Lesion
Christian Schmidt, Mark Obermann
Diseases (Basel, Switzerland)
|
January 3, 2018
Risk Evaluation Requires an Independent Mind
Christian Schmidt, Joachim Storsberg
Page
of 53